A thermoresponsive nanocarrier for mitochondria-targeted drug delivery

Chem Commun (Camb). 2019 Apr 2;55(28):4051-4054. doi: 10.1039/c9cc00603f.

Abstract

Mitochondria emerge as an important target for cancer therapy. Herein, by taking advantage of the recently reported high temperature of mitochondria, a well-tuned thermoresponsive nanocarrier was developed for specifically delivering the anticancer drug, paclitaxel (PTX), to mitochondria in cancer cells. The temperature-dependent delivery of drugs to mitochondria represents a novel anticancer strategy.

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Cell Line
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Carriers / chemistry*
  • Drug Screening Assays, Antitumor
  • Humans
  • Mice
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Paclitaxel / administration & dosage*
  • Paclitaxel / pharmacology
  • Structure-Activity Relationship
  • Temperature*

Substances

  • Antineoplastic Agents, Phytogenic
  • Drug Carriers
  • Paclitaxel